Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Patient Care
January 01, 2016 11:00 PM

All medication treatments for opioid addiction argued to be 'essential' insurance benefit

Bob Herman
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images
    Buprenorphine is used as part of a therapy to help people reduce their craving for opioids.

    As opioid overdoses continue to rise across the country, providers are battling large insurers and pharmacy benefit managers that argue coverage of treatments for people with opioid addictions should be left up to the payers' discretion.

    More than 28,600 people died in 2014 as the result of overdoses from prescription painkillers, heroin and other opioids, according to a recent analysis from the Centers for Disease Control and Prevention.

    Numerous hospital associations, psychiatrists, primary-care physicians, executives at drug-abuse treatment centers and recovering opioid addicts recently submitted comments to the CMS urging that all health plans sold on the federal exchange cover medications that help overcome substance abuse.

    The Affordable Care Act requires health insurers to cover 10 essential health benefits, including prescription drugs and substance-use disorder services. But it has been unclear whether plans on the federal marketplace must cover the full range of medication-assisted treatment, or MAT. Many commercial insurers pay for MAT, a therapy in which people combine medication with counseling to reduce their craving for opioids.

    The Substance Abuse and Mental Health Services Administration and the National Institute on Drug Abuse have found MAT to be effective for people suffering from opioid addiction. The NIDA said MAT “increases patient retention and decreases drug use, infectious-disease transmission and criminal activity,” and it also saves money by keeping people out of hospitals and outpatient centers.

    But some providers and patient advocates say insurers have instituted high copays and other barriers that result in inadequate coverage and access to the treatment.

    Methadone and buprenorphine, the two most common drugs used in MAT, could annually cost someone thousands of dollars out of pocket.

    SAMHSA officials also have argued there are misconceptions and stigmas associated with addicts and MAT, which could make treatment harder to access.

    Travis Simerly and his wife are MAT patients who take methadone daily, according to Simerly's comments to the CMS. He wrote that his insurance company, Blue Cross and Blue Shield of Tennessee, denied their claim because the company covers only buprenorphine for addiction treatment. Simerly called the coverage discrepancy a “farce” and said all MAT drugs should be held to the same benefits standards. Blue Cross did not immediately respond for comment.

    MH Takeaways

    Insurers and pharmacy benefit management companies are arguing that coverage for opioid addiction treatment should be left up to their discretion.

    “Our addiction treatment is by far our largest medical expense, and for it to not be covered by the insurance that we are required by law to have is nothing more than a proverbial kick in the teeth,” Simerly wrote.

    Dozens of individual physicians submitted letters asking the CMS to mandate that all federal health plans fully cover MAT as part of the essential health benefits.

    “There is clinical consensus that MAT is the most effective treatment for opioid addiction,” said Dr. Shelly Greenfield, a psychiatrist at Harvard Medical School and McLean Hospital in Belmont, Mass. “The use of medications reduces opioid use and overdose rates, and helps retain people in treatment longer, which is associated with better outcomes.”

    But the country's largest health insurers, PBMs and lobbying groups want the CMS to punt the proposal. America's Health Insurance Plans, the Blue Cross and Blue Shield Association, the Pharmaceutical Care Management Association, Express Scripts Holding Co., CVS Health Corp. and UnitedHealthcare said they shared the federal government's concern over the “devastating effect of opioid abuse,” but they argued they should not be forced to pay for specific treatments that could curb the problem.

    “We are concerned that by mandating specific benefits within an (essential health benefits) category, CMS may establish a precedent of imposing essential health benefit mandates in the future,” Blue Cross and Blue Shield wrote. “Requiring plans to cover specific drugs within a category and class would conflict with this carefully established balance between coverage mandates and affordability, which in turn would lead to increases in premiums at a time when CMS is seeking to ensure that consumers have access to affordable coverage and that there is stability in the market.”

    The companies and groups said the government should instead rely on individual insurers and their pharmacy and therapeutics committees to determine coverage for specific drugs.

    However, the Association for Community Affiliated Plans—the trade group that represents small safety net health plans that cover many low-income people—disagreed with the large players, saying the industry should be prodded to fully cover MAT.

    “ACAP plans are cognizant of the opioid addiction epidemic and are investing in efforts to address opioid abuse,” the organization said. “We are supportive of CMS adding MAT to the essential health benefits.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    google.jpg
    Google to open three more employee wellness centers in 2024
    obesity overweight patient
    Why more doctors are seeking obesity certification
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing